• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国西南部妇女 HPV 56 型长控制区 E6、E7 和 L1 的系统发育和多态性。

Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China.

机构信息

Key Laboratory of Bio‑Resources and Eco‑Environment, Ministry of Education, Institute of Medical Genetics, College of Life Science, Sichuan University, Chengdu, Sichuan 610064, P.R. China.

出版信息

Mol Med Rep. 2018 May;17(5):7131-7141. doi: 10.3892/mmr.2018.8743. Epub 2018 Mar 14.

DOI:10.3892/mmr.2018.8743
PMID:29568922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5928666/
Abstract

Globally, human papillomavirus (HPV)‑56 accounts for a small proportion of all high‑risk HPV types; however, HPV‑56 is detected at a higher rate in Asia, particularly in southwest China. The present study analyzed polymorphisms, intratypic variants, and genetic variability in the long control regions (LCR), E6, E7, and L1 of HPV‑56 (n=75). The LCRs, E6, E7 and L1 were sequenced using a polymerase chain reaction and the sequences were submitted to GenBank. Maximum‑likelihood trees were constructed using Kimura's two‑parameter model, followed by secondary structure analysis and protein damaging prediction. Additionally, in order to assess the effect of variations in the LCR on putative binding sites for cellular proteins, MATCH server was used. Finally, the selection pressures of the E6‑E7 and L1 genes were estimated. A total of 18 point substitutions, a 42‑bp deletion and a 19‑bp deletion of LCR were identified. Some of those mutations are embedded in the putative binding sites for transcription factors. 18 single nucleotide changes occurred in the E6‑E7 sequence, 11/18 were non‑synonymous substitutions and 7/18 were synonymous mutations. A total 24 single nucleotide changes were identified in the L1 sequence, 6/24 being non‑synonymous mutations and 18/24 synonymous mutations. Selective pressure analysis predicted that the majority of mutations of HPV‑56 E6, E7 and L1 were of positive selection. The phylogenetic tree demonstrated that the isolates distributed in two lineages. Data on the prevalence and genetic variation of HPV‑56 types in southwest China may aid future studies on viral molecular mechanisms and contribute to future investigations of diagnostic probes and therapeutic vaccines.

摘要

全球范围内,人乳头瘤病毒(HPV)-56 在所有高危 HPV 型别中仅占一小部分;然而,HPV-56 在亚洲的检出率较高,尤其是在中国西南部。本研究分析了 HPV-56(n=75)的长控制区(LCR)、E6、E7 和 L1 中的多态性、同型内变体和遗传变异。使用聚合酶链反应对 LCRs、E6、E7 和 L1 进行测序,并将序列提交至 GenBank。使用 Kimura 的双参数模型构建最大似然树,随后进行二级结构分析和蛋白损伤预测。此外,为了评估 LCR 变异对细胞蛋白可能结合位点的影响,使用了 MATCH 服务器。最后,估计了 E6-E7 和 L1 基因的选择压力。共鉴定出 18 个点突变、42bp 缺失和 LCR 19bp 缺失。其中一些突变嵌入了转录因子的潜在结合位点。E6-E7 序列中发生了 18 个单核苷酸变化,其中 11/18 为非同义取代,7/18 为同义突变。L1 序列中总共鉴定出 24 个单核苷酸变化,其中 6/24 为非同义突变,18/24 为同义突变。选择压力分析预测 HPV-56 E6、E7 和 L1 的大多数突变均为正选择。系统发育树表明,分离株分布在两个谱系中。中国西南部 HPV-56 型的流行率和遗传变异数据可能有助于未来对病毒分子机制的研究,并为未来诊断探针和治疗性疫苗的研究做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/fb22f054d6dd/MMR-17-05-7131-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/43c82e4d4d91/MMR-17-05-7131-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/b1416fd78119/MMR-17-05-7131-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/dd4d138e17ec/MMR-17-05-7131-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/1eaab95b97f5/MMR-17-05-7131-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/fb22f054d6dd/MMR-17-05-7131-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/43c82e4d4d91/MMR-17-05-7131-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/b1416fd78119/MMR-17-05-7131-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/dd4d138e17ec/MMR-17-05-7131-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/1eaab95b97f5/MMR-17-05-7131-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51fc/5928666/fb22f054d6dd/MMR-17-05-7131-g05.jpg

相似文献

1
Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China.中国西南部妇女 HPV 56 型长控制区 E6、E7 和 L1 的系统发育和多态性。
Mol Med Rep. 2018 May;17(5):7131-7141. doi: 10.3892/mmr.2018.8743. Epub 2018 Mar 14.
2
Genetic variability and lineage phylogeny of human papillomavirus type-16 and -53 based on the E6, E7, and L1 genes in Southwest China.基于E6、E7和L1基因的中国西南地区16型和53型人乳头瘤病毒的遗传变异性和谱系系统发育
Gene. 2016 Oct 30;592(1):49-59. doi: 10.1016/j.gene.2016.07.039. Epub 2016 Jul 21.
3
The polymorphisms of LCR, E6, and E7 of HPV-58 isolates in Yunnan, Southwest China.中国西南云南省 HPV-58 分离株 LCR、E6 和 E7 的多态性。
Virol J. 2018 Apr 25;15(1):76. doi: 10.1186/s12985-018-0986-7.
4
Genetic variability of human papillomavirus type 51 E6, E7, L1 and L2 genes in Southwest China.中国西南地区人乳头瘤病毒 51 型 E6、E7、L1 和 L2 基因的遗传变异。
Gene. 2019 Mar 30;690:99-112. doi: 10.1016/j.gene.2018.12.032. Epub 2018 Dec 21.
5
E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China.在中国西南部发现的人乳头瘤病毒58型和33型中的E6和E7基因多态性
PLoS One. 2017 Jan 31;12(1):e0171140. doi: 10.1371/journal.pone.0171140. eCollection 2017.
6
Genetic variability of human papillomavirus type 39 based on E6, E7 and L1 genes in Southwest China.基于 HPV39 型 E6、E7 和 L1 基因的中国西南地区人乳头瘤病毒遗传变异。
Virol J. 2021 Apr 8;18(1):72. doi: 10.1186/s12985-021-01528-w.
7
The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.中国四川地区人乳头瘤病毒 52 型分离株中 E6、E7 和 LCR 的遗传变异性、系统发生和功能意义。
Virol J. 2021 May 3;18(1):94. doi: 10.1186/s12985-021-01565-5.
8
Genetic variability in E6, E7, and L1 genes of human papillomavirus genotype 52 from Southwest China.中国西南地区人乳头瘤病毒52型E6、E7和L1基因的遗传变异性
Gene. 2016 Jul 1;585(1):110-118. doi: 10.1016/j.gene.2016.03.007. Epub 2016 Mar 9.
9
Genetic variation of E6 and E7 genes of human papillomavirus 52 from Central China.中国中部地区人乳头瘤病毒 52 型 E6 和 E7 基因的遗传变异。
J Med Virol. 2021 Jun;93(6):3849-3856. doi: 10.1002/jmv.26690. Epub 2020 Dec 1.
10
Genetic variability of HPV-58 E6 and E7 genes in Southwest China.中国西南地区人乳头瘤病毒58型E6和E7基因的遗传变异性
Infect Genet Evol. 2014 Jan;21:395-400. doi: 10.1016/j.meegid.2013.12.009. Epub 2013 Dec 22.

引用本文的文献

1
Transcriptomic Analysis of HPV-Positive Oesophageal Tissue Reveals Upregulation of Genes Linked to Cell Cycle and DNA Replication.人乳头瘤病毒阳性食管组织的转录组分析揭示了与细胞周期和DNA复制相关基因的上调。
Int J Mol Sci. 2024 Dec 24;26(1):56. doi: 10.3390/ijms26010056.
2
The polymorphism analysis and therapy vaccine target epitopes screening of HPV-35 E6 E7 among the threaten α-9 HPV in Sichuan area.四川地区高危型 HPV-35 型 E6、E7 基因多态性分析及其治疗性疫苗靶抗原表位的筛选
Virol J. 2024 Sep 9;21(1):213. doi: 10.1186/s12985-024-02357-3.
3
Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest.

本文引用的文献

1
Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345 HPV Genotyping Results from China's Largest CAP Certified Laboratory.中国HPV感染的患病率及基因型分布:来自中国最大的CAP认证实验室的51345份HPV基因分型结果分析
J Cancer. 2016 May 25;7(9):1037-43. doi: 10.7150/jca.14971. eCollection 2016.
2
Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.人乳头瘤病毒31、33、45、56和58型感染的变异特异性持续性与宫颈上皮内瘤变风险
Int J Cancer. 2016 Sep 1;139(5):1098-105. doi: 10.1002/ijc.30164. Epub 2016 May 14.
3
吲哚 - 3 - 甲醇,一种植物化学芳烃受体配体,可诱导UBE2L3的mRNA过表达并导致细胞增殖停滞。
Curr Issues Mol Biol. 2022 May 8;44(5):2054-2068. doi: 10.3390/cimb44050139.
4
Detecting Human Papillomavirus Type 16 in Cervical Cancer Patients with Molecular Variation of Gene L1 in Riau Province Indonesia.印度尼西亚廖内省宫颈癌患者中基因 L1 分子变异检测人乳头瘤病毒 16 型。
Asian Pac J Cancer Prev. 2022 Jan 1;23(1):87-92. doi: 10.31557/APJCP.2022.23.1.87.
5
Combination Therapies for HPV-Associated Malignancies.人乳头瘤病毒相关恶性肿瘤的联合治疗
J Clin Cell Immunol. 2021;12(1). Epub 2020 Dec 28.
6
Therapeutic Vaccines for HPV-Associated Malignancies.用于人乳头瘤病毒相关恶性肿瘤的治疗性疫苗
Immunotargets Ther. 2020 Oct 7;9:167-200. doi: 10.2147/ITT.S273327. eCollection 2020.
7
Aristocratic human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.人乳头瘤病毒的贵族驱动:干扰素联合锌治疗潜力的研究。
Mol Cell Biochem. 2021 Feb;476(2):757-765. doi: 10.1007/s11010-020-03941-1. Epub 2020 Oct 24.
8
Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives.人乳头瘤病毒感染与宫颈癌:流行病学、筛查及疫苗接种——当前观点综述
J Oncol. 2019 Oct 10;2019:3257939. doi: 10.1155/2019/3257939. eCollection 2019.
Gardasil-9: A global survey of projected efficacy.
九价人乳头瘤病毒重组疫苗:全球预计效力调查
Antiviral Res. 2016 Jun;130:101-9. doi: 10.1016/j.antiviral.2016.03.016. Epub 2016 Apr 1.
4
Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population.中国人群中16型人乳头瘤病毒变异体分析与宫颈癌风险
Virology. 2016 Jan 15;488:156-61. doi: 10.1016/j.virol.2015.11.016. Epub 2015 Nov 30.
5
Characteristics of HPV prevalence in Sichuan Province, China.中国四川省人乳头瘤病毒(HPV)流行特征
Int J Gynaecol Obstet. 2015 Dec;131(3):277-80. doi: 10.1016/j.ijgo.2015.06.027. Epub 2015 Sep 6.
6
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.中国37个城市人乳头瘤病毒感染的全国患病率及病毒基因型分布
BMC Infect Dis. 2015 Jul 4;15:257. doi: 10.1186/s12879-015-0998-5.
7
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
8
Are 20 human papillomavirus types causing cervical cancer?20种人乳头瘤病毒类型会引发宫颈癌吗?
J Pathol. 2014 Dec;234(4):431-5. doi: 10.1002/path.4424.
9
Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China.中国西南地区女性宫颈癌中 HPV 及 HPV16/18 E6/E7 基因变异的流行情况。
J Med Virol. 2014 Nov;86(11):1926-36. doi: 10.1002/jmv.24043. Epub 2014 Aug 11.
10
Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.HPV16 型假病毒,L1 主要衣壳蛋白 FG 环中存在少数点突变,可能逃避实际或未来的疫苗接种,用于基因治疗。
Mol Biotechnol. 2014 May;56(5):479-86. doi: 10.1007/s12033-014-9745-1.